The Archive · 5 posts
Explore Wellnex Life Limited (WNX) on LSE! 🌟 Investing in health and wellness innovation, WNX is shaping the future of wellbeing! 🌿
Wellnex Life has agreed to sell Pain Away for up to A$21.3 million, enabling it to clear debt and reshape its remaining business.
August 6, 2026
Showing 4 of 5 posts
Wellnex Life ended FY26 with stronger revenue, positive quarterly operating cash flow and $862,000 in cash, but financing remains important.
JoshuaJuly 31, 2026
Wellnex Life extends Haleon supply deal to 2027, boosting credibility but financial terms undisclosed.
JoshuaApril 2, 2026
Wellnex Life's strategic discipline is paying off: H1 revenue rose 8% with a sharp jump in gross margin, achieving operational breakeven in Q2. Funding remains the key hurdle.
JoshuaFebruary 27, 2026
Wellnex Life's Q3 cash receipts surge 69% to $6.6m, achieving positive operational cash flow after transformative AIM market admission. Growth driven by brand sales & IP licensing.
JoshuaApril 9, 2025
February 27, 2026